Camlin Fine Sciences share price
NSE: CAMLINFINEChemicalsSpecialty Chemicals
Camlin Fine Sciences at a glance
Camlin Fine Sciences (NSE: CAMLINFINE) closed at ₹85.67 on 22 Oct 2026, down 1.42% on the day. With a market capitalisation of ₹1,646 Cr, it ranks 1222nd by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Chemicals sector; its industry is Specialty Chemicals.
Its return on equity was −15.5% in FY25. Over the past year the share price has fallen 54.9%. Its 52-week range is ₹83.38 (22 Oct 2026) to ₹204.57 (23 Oct 2025); the last close is 58.1% below the high. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹425 Cr (−2.9% year on year) and net profit ₹85 Cr, on a consolidated basis. Promoters held 48.03% of the company as of 30 Jun 2026; 16.21% of promoter shares were pledged.
Key numbers
- Market cap
- ₹1,646 CrRank 1222 on NSE
- Price to book
- 3.51×FY25
- EPS (TTM)
- ₹1.39to Q4 FY26
- ROE
- −15.5%FY25
- ROCE
- 13.5%FY25
- Debt to equity
- 0.72FY25
- Net profit margin
- −9.5%FY25
- Book value / share
- ₹47.81FY25
- 52-week high
- ₹204.5723 Oct 2025
- 52-week low
- ₹83.3822 Oct 2026
- 1-year return
- −54.9%
- RSI (14-day)
- 35.3
Returns to 22 Oct 2026
| Period | 1 day | 1 week | 1 month | 3 months | 1 year |
|---|---|---|---|---|---|
| Price change | −1.42% | −4.1% | −13.7% | −29.4% | −54.9% |
Camlin Fine Sciences quarterly results
| Quarter | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹396 Cr | ₹423 Cr | ₹433 Cr | ₹437 Cr | ₹424 Cr | ₹460 Cr | ₹457 Cr | ₹425 Cr |
| Revenue YoY | −5.7% | +4.2% | +12.3% | +8.9% | +7.0% | +8.7% | +5.5% | −2.9% |
| Net profit | −₹35 Cr | −₹117 Cr | −₹6 Cr | −₹2 Cr | −₹12 Cr | −₹15 Cr | −₹37 Cr | ₹85 Cr |
| Net profit YoY | −388.3% | — | — | — | — | — | — | — |
| Net margin | −8.8% | −27.6% | −1.3% | −0.4% | −2.7% | −3.2% | −8.1% | 20.0% |
| EPS | −₹2.03 | −₹5.98 | −₹0.24 | −₹0.04 | −₹0.52 | −₹0.77 | −₹1.91 | ₹4.59 |
Camlin Fine Sciences financials
| Item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Revenue | ₹1,049 Cr | ₹1,187 Cr | ₹1,412 Cr | ₹1,682 Cr | ₹1,613 Cr | ₹1,667 Cr |
| Operating profit | ₹58 Cr | ₹105 Cr | ₹94 Cr | ₹90 Cr | −₹49 Cr | ₹59 Cr |
| Net profit | ₹30 Cr | ₹65 Cr | ₹61 Cr | ₹40 Cr | −₹105 Cr | −₹159 Cr |
| EPS (₹) | ₹3.00 | ₹4.00 | ₹5.00 | ₹3.00 | −₹6.00 | −₹8.00 |
| Cash from operations | ₹86 Cr | ₹117 Cr | ₹145 Cr | ₹51 Cr | ₹139 Cr | ₹27 Cr |
| Total debt | ₹212 Cr | ₹273 Cr | ₹388 Cr | ₹408 Cr | ₹333 Cr | ₹268 Cr |
| Shareholders' equity | ₹400 Cr | ₹640 Cr | ₹745 Cr | ₹816 Cr | ₹861 Cr | ₹898 Cr |
Camlin Fine Sciences shareholding pattern
| Holder | 30 Jun 2025 | 30 Sep 2025 | 3 Dec 2025 | 31 Dec 2025 | 31 Mar 2026 | 30 Jun 2026 |
|---|---|---|---|---|---|---|
| Promoters | 49.10% | 49.08% | 48.03% | 48.03% | 48.03% | 48.03% |
| Foreign institutions | 2.88% | 2.12% | 2.15% | 2.12% | 0.94% | 0.91% |
| Domestic institutions | 4.14% | 5.48% | 7.78% | 7.77% | 7.70% | 5.42% |
| Non-institutions | 43.87% | 43.33% | 42.05% | 42.08% | 43.32% | 45.64% |
| Promoter shares pledged | 10.84% | 10.84% | 10.84% | 10.84% | 16.58% | 16.21% |
Camlin Fine Sciences vs peers
The listed Chemicals companies nearest to Camlin Fine Sciences by market capitalisation.
| Company | Price | 1 day | 1 year | Market cap | P/E | ROE |
|---|---|---|---|---|---|---|
| GOCLCORPGOCL Corporation | ₹343.10 | −0.78% | +4.2% | ₹1,701 Cr | 6.1 | — |
| CAMLINFINECamlin Fine Sciences | ₹85.67 | −1.42% | −54.9% | ₹1,646 Cr | — | — |
| VIDHIINGVidhi Specialty Food Ingredients | ₹329.20 | −1.11% | −8.6% | ₹1,644 Cr | 33.6 | — |
| BHARATRASBharat Rasayan | ₹978.00 | +0.30% | −58.8% | ₹1,626 Cr | 2.8 | — |
| PAUSHAKLTDPaushak | ₹658.50 | +1.59% | — | ₹1,624 Cr | 41.3 | — |
| INSECTICIDInsecticides (India) | ₹547.10 | −2.08% | −24.3% | ₹1,592 Cr | 11.4 | — |
| CITURGIACiturgia Bioche | — | — | — | ₹1,583 Cr | — | — |
Ask anything about Camlin Fine Sciences
Pivot answers on the live chart with evidence you can check, and tests strategies against CAMLINFINE's own history. Try: “Why has CAMLINFINE moved over the last three months?” · “Backtest a 50-day moving-average crossover on CAMLINFINE over five years” · “Compare CAMLINFINE with GOCLCORP on margins and valuation”
Frequently asked questions about Camlin Fine Sciences
What is the share price of Camlin Fine Sciences today?
Camlin Fine Sciences (NSE: CAMLINFINE) last closed at ₹85.67 on 22 Oct 2026. Its 52-week high is ₹204.57 and its 52-week low is ₹83.38.
What is the market cap of Camlin Fine Sciences?
Camlin Fine Sciences' market capitalisation is ₹1,646 Cr (₹1,646 Cr) at the 22 Oct 2026 close, ranking 1222nd among the NSE companies Pivot tracks.
What is the ROE and ROCE of Camlin Fine Sciences?
Return on equity was −15.5% in FY25 and return on capital employed was 13.5% in FY25 (consolidated figures).
Is Camlin Fine Sciences a debt-free company?
No. Camlin Fine Sciences' debt-to-equity ratio was 0.72 in FY25, with total debt of ₹268 Cr.
What were Camlin Fine Sciences' latest quarterly results?
For Q4 FY26 (quarter ended 31 Mar 2026), Camlin Fine Sciences reported revenue of ₹425 Cr, −2.9% year on year, and net profit of ₹85 Cr.
How has Camlin Fine Sciences stock performed over the last year?
Camlin Fine Sciences' share price has fallen 54.9% over the past year, −29.4% over three months and −13.7% over one month, to the 22 Oct 2026 close.
What is the shareholding pattern of Camlin Fine Sciences?
As of 30 Jun 2026: promoters 48.03%, foreign institutions 0.91%, domestic institutions 5.42%, non-institutions 45.64%. 16.21% of promoter shares were pledged.
Who are Camlin Fine Sciences' competitors?
The listed Chemicals companies closest to Camlin Fine Sciences by market cap are GOCL Corporation, Vidhi Specialty Food Ingredients, Bharat Rasayan, Paushak, Insecticides (India) and Citurgia Bioche.
Is Camlin Fine Sciences a good stock to buy?
Pivot does not give buy or sell recommendations. This page sets out Camlin Fine Sciences' price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on CAMLINFINE against its own history before risking money. This is analysis, not financial advice.
Sources and method
Prices: NSE daily closes to 22 Oct 2026 (returns and ratios at the 22 Oct 2026 close). Fundamentals: company filings via Moneycontrol, consolidated where available. Shareholding: exchange shareholding-pattern filings. The 52-week range uses intraday highs and lows; the chart marks closing prices. P/E is the last close over trailing twelve-month EPS. Market-cap rank is among the 4,183 NSE companies Pivot tracks; SEBI's bands call the top 100 large-cap and the next 150 mid-cap. Figures marked “—” are not available rather than zero. This is analysis, not financial advice.
More: all Chemicals stocks · companies starting with C · all NSE stocks · this page as text